Last reviewed · How we verify
NCT06127810
MRI Gadopiclenol Enhanced Imaging of CNS Tumors
trial testing CE MRI on 0.064T Scanner in Image. Withdrawn.
30 December 2024
Quick facts
| Lead sponsor | Medical University of South Carolina |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 30 December 2024 |
| Primary completion | 30 December 2024 |
| Estimated completion | 30 December 2024 |
Drugs / interventions tested
- CE MRI on 0.064T Scanner
- Gadopiclenol (GADOPICLENOL) — full drug profile →
Conditions studied
- Image — all drugs for Image →
Sponsor
Medical University of South Carolina
Who can join
18 and older, any sex, with Image. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this pilot study is to compare a standard of care MRI scan to a non-standard of care MR imaging with portable (0.064 Tesla) MRI following the administration of non-SOC contrast called Gadopiclenol on 10 subjects with known brain tumors. Participants will be randomized to receive either standard MRI or portable MRI first following contrast injection
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06127810
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Image
Currently open trials in the same condition.
- NCT06489665 — Imaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective Stu · recruiting
- NCT06017193 — Ultrasound for Socket Healing Evaluation · recruiting
- NCT05697406 — HP Pyruvate MRI in Cancers · Phase 1, PHASE2 · recruiting
- NCT06533709 — Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data · recruiting
- NCT05965817 — Fluorescence-guided Resection Of Colorectal Liver Metastases Using SGM-101 and Indocyanine GREEN · Phase 2 · recruiting
Other Medical University of South Carolina trials
Trials by the same sponsor.
- NCT06491264 — Multiparameter Optimized tES for Memory in Aging · NA · withdrawn
- NCT07513389 — Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · Phase 2 · not yet recruiting
- NCT03101917 — Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE) · NA · not yet recruiting
- NCT07149207 — Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors · Phase 2 · recruiting
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06127810 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of South Carolina
- Last refreshed: 4 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06127810.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing